Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 15, 2022

SELL
$3.02 - $4.56 $248,829 - $375,716
-82,394 Closed
0 $0
Q1 2022

May 16, 2022

BUY
$3.92 - $7.48 $156,074 - $297,816
39,815 Added 93.51%
82,394 $367,000
Q4 2021

Feb 14, 2022

BUY
$6.7 - $11.38 $102,603 - $174,273
15,314 Added 56.17%
42,579 $307,000
Q3 2021

Nov 15, 2021

BUY
$10.11 - $17.56 $275,649 - $478,773
27,265 New
27,265 $293,000
Q3 2020

Nov 16, 2020

SELL
$8.56 - $11.6 $132,406 - $179,428
-15,468 Closed
0 $0
Q2 2020

Aug 17, 2020

SELL
$6.63 - $12.85 $74,594 - $144,575
-11,251 Reduced 42.11%
15,468 $155,000
Q1 2020

May 15, 2020

BUY
$6.94 - $14.42 $185,429 - $385,287
26,719 New
26,719 $196,000

Others Institutions Holding ICAD

About ICAD INC


  • Ticker ICAD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 25,333,900
  • Market Cap $49.9M
  • Description
  • iCAD, Inc. provides image analysis, workflow solutions, and radiation therapy for the treatment of cancer in the United States. It operates through two segments, Cancer Detection and Cancer Therapy. The company offers PowerLook platform, which hosts the AI algorithm solutions and manages the communications between imaging acquisition systems, an...
More about ICAD
Track This Portfolio

Track Engineers Gate Manager LP Portfolio

Follow Engineers Gate Manager LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Engineers Gate Manager LP, based on Form 13F filings with the SEC.

News

Stay updated on Engineers Gate Manager LP with notifications on news.